This is the authors' abstract. We don't add key points for this paper.
In view of markedly reduced darunavir and cobicistat exposures during pregnancy, this combination is not recommended in HIV-1-infected pregnant women.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Crauwels et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: